KA
Kiran Aher
Shri Vile Parle Kelavani Mandal's Institute of Pharmacy Dhule, Amrutvahini College of Pharmacy, Jawaharlal Nehru Technological University Hyderabad, GlaxoSmithKline (India)
Employment
-
Shri Vile Parle Kelavani Mandal's Institute of Pharmacy Dhule Associate Professor2018 - Present
-
Amrutvahini College of Pharmacy Assistant Professor2010 - 2018
-
GlaxoSmithKline (India) Executive2007 - 2010
-
Amrutvahini College of Pharmacy Lecturer2006 - 2007
Education
-
Jawaharlal Nehru Technological University Hyderabad Ph.D2009 - 2014
-
All India Shri Shivaji Memorial Society's College of Pharmacy M. Pharm2004 - 2006
-
Pravara Rural College of Pharmacy B. Pharm2000 - 2004
Projects & Funding
Projects & funding information is unavailable.
Publications (20)
- Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression Save
- Development and Validation of an ICH-Compliant Optimized RP-HPLC Method for Quantitative Analysis of Favipiravir Save
- Genes adaptability and NOL6 protein inhibition studies of fabricated flavan-3-ols lead skeleton intended to treat breast carcinoma Save
- Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma Save
- Development and characterization of carboxylated copper oxide conjugated polymeric nanocomposites and correlating with computational techniques Save
- Novel Approach for Manufacturing and Biological Evaluation of Ayurvedic Fermented Cardioprotective Formulation Arjunarishta Save
- Artificial neural networks for the prediction of mechanical properties of CGNP/PLGA nanocomposites Save
- Environmentally Friendly Analytical Methods for Quantitative Measurement of Sofosbuvir in Pharmaceutical Formulations: Comparison of HPTLC and UV Spectrophotometric Approaches Save
- Strategies of nanomedicine for targeting the signaling pathways of Colorectal cancer Save
- Development and validation of UV spectrophotometric method and high performance thin layer chromatographic (HPTLC) method for estimation of teneligliptin hydrobromide in pharmaceutical preparation Save